n-methyl-3,4-methylenedioxyamphetamine has been researched along with Developmental Psychomotor Disorders in 4 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parrott, AC | 2 |
Buchanan, T | 2 |
Heffernan, TM | 1 |
Scholey, A | 1 |
Ling, J | 2 |
Rodgers, J | 2 |
Sumnall, HR | 1 |
Jerome, L | 1 |
Doblin, R | 1 |
Mithoefer, MC | 1 |
Scholey, AB | 1 |
Heffernan, T | 1 |
Uys, JD | 1 |
Niesink, RJ | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Developmental Psychomotor Disorders
Article | Year |
---|---|
Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
Topics: Anxiety; Body Temperature; Depression; Dopamine; Hallucinogens; Humans; Hydroxybutyrates; N-Methyl-3 | 2005 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Developmental Psychomotor Disorders
Article | Year |
---|---|
Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
Topics: Brain; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Parki | 2003 |
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
Topics: Animals; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Neu | 2004 |
The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).
Topics: Animals; Clinical Trials as Topic; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-meth | 2004 |